Miyuki Miki
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD.
Journal: Modern rheumatology
Published: May 23, 2019
Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice.
Journal: Cellular immunology
Published: October 13, 2015
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
Journal: Medical oncology (Northwood, London, England)
Published: August 01, 2015
CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease.
Journal: Biomedical research (Tokyo, Japan)
Published: April 17, 2015
Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
Journal: PloS one
Published: November 29, 2014
IgG4-related disease: diagnostic methods and therapeutic strategies in Japan.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: October 17, 2014
Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 07, 2014
Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 27, 2013
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
Journal: Anticancer research
Published: December 11, 2012
Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 16, 2012
Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
Journal: Anticancer research
Published: April 12, 2012
CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice.
Journal: International immunology
Published: February 21, 2012
Last Updated: 09/26/2026